Geron
GERN
$4.08
Share price
3.82%
Change (1 day)
59.38%
Change (1 year)
Categories
Operating Margin for Geron (GERN)
Operating Margin as of May 2024 (TTM): -23,808.90%
According to Geron's latest financial reports and stock price the company's current Operating Margin is -23,808.90%. At the end of 2022 the company had an Operating Margin of -23,808.89%.
Operating Margin history for Geron from 2001 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -23,808.89% | 185.64% |
| 2021 | -8,335.39% | -72.11% |
| 2020 | -29,888.14% | 100.57% |
| 2019 | -14,901.74% | 487.97% |
| 2018 | -2,534.43% | -3.31% |
| 2017 | -2,621.22% | 446.84% |
| 2016 | -479.34% | -379102.52% |
| 2015 | 0.13% | -100% |
| 2014 | -3,093.67% | 3.42% |
| 2013 | -2,991.35% | 17.65% |
| 2012 | -2,542.67% | -31.63% |
| 2011 | -3,718.91% | 73.97% |
| 2010 | -2,137.72% | -47.47% |
| 2009 | -4,069.18% | 70.13% |
| 2008 | -2,391.87% | 190.12% |
| 2007 | -824.44% | -42.95% |
| 2006 | -1,445.22% | -88.89% |
| 2005 | -13,003.45% | 278.93% |
| 2004 | -3,431.62% | 33.49% |
| 2003 | -2,570.70% | -10.13% |
| 2002 | -2,860.58% | 195.7% |
| 2001 | -967.38% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Gilead Sciences GILD | 26.84% | -100.11% | 🇺🇸 USA |
 Incyte INCY | 15.90% | -100.07% | 🇺🇸 USA |
 CTI BioPharma
CTIC | -172.37% | -99.28% | 🇺🇸 USA |
 Bio-Techne TECH | 27.25% | -100.11% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | 0.00% | N/A | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.